Skip to main content

HighTower Advisors, LLC

SEC CIK
0001462245
Latest filing
Aug 25, 2026

MRKR holding history

Marker Therapeutics, Inc. in every 13F filed by HighTower Advisors, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

MRKR overviewAll 13F holders of MRKRFull Q2 2026 holdings

Shares (Q1 2023)
0
Sold out in Q1 2023
Value
$0
% of portfolio
0.0%
Quarters held
8
Since Q1 2021
Holdings of MRKR by HighTower Advisors, LLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q1 20230$00.0%−2,208−100.0%Sold outConverted for a 1-for-10 splitHolders
Q4 202222,078$6.00K<0.1%+5,000+29.3%AddedHolders
Q3 202217,078$6.00K<0.1%00.0%UnchangedHolders
Q2 202217,078$6.00K<0.1%00.0%UnchangedHolders
Q1 202217,078$7.00K<0.1%00.0%UnchangedHolders
Q4 202117,078$16.0K<0.1%00.0%UnchangedHolders
Q3 202117,078$29.0K<0.1%−100−0.6%ReducedHolders
Q2 202117,178$47.0K<0.1%00.0%UnchangedHolders
Q1 202117,178$38.0K<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.